Department of Cardiology, Larissa University Hospital, Larissa, Greece.
Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.
Eur J Heart Fail. 2016 Jul;18(7):744-58. doi: 10.1002/ejhf.600. Epub 2016 Jun 30.
Several co-existing diseases and/or conditions (co-morbidities) are present in patients with heart failure (HF), with diverse clinical relevance. Multiple mechanisms may underlie the co-existence of HF and co-morbidities, including direct causation, associated risk factors, heterogeneity, and independence. The complex inter-relationship of co-morbidities and their impact on the cardiovascular system contribute to the features of HF, both with reduced (HFrEF) and preserved ejection fraction (HFpEF). The purpose of this work is to provide an overview of the contribution of major cardiac and non-cardiac co-morbidities to HF development and outcomes, in the context of both HFpEF and HFrEF. Accordingly, epidemiological evidence linking co-morbidities to HF and the effect of prevalent and incident co-morbidities on HF outcome will be reviewed.
心力衰竭(HF)患者常同时存在多种共存疾病和/或病症(合并症),具有不同的临床相关性。多种机制可能导致 HF 与合并症同时存在,包括直接因果关系、相关危险因素、异质性和独立性。合并症之间的复杂相互关系及其对心血管系统的影响导致了 HF 的特征,包括射血分数降低(HFrEF)和射血分数保留(HFpEF)。本研究的目的是概述主要心脏和非心脏合并症在 HFpEF 和 HFrEF 两种情况下对 HF 发生和结局的影响。因此,将回顾合并症与 HF 的流行病学证据以及现有和新发合并症对 HF 结局的影响。